test3

Attention Virginia Cancer Specialists Patients: There is a system outage and certain functions, such as scheduling, may not be available today. We will call patients to schedule any upcoming appointments when the system is back online. Our clinics remain open and previously scheduled appointments will continue as planned. We apologize for any inconvenience.

 

Exploring Why Testing in Lung Cancer is Important to Treatment Decisions - Alex Spira, MD, PhD, FACP

Virginia Cancer Specialists Practice Blog

February 23, 2021
Virginia Cancer Specialists » VCS Practice News » Physicians » VCS Practice News » Alex Spira MD PhD FACP » Exploring Why Testing in Lung Cancer is Important to Treatment Decisions – Alex Spira, MD, PhD, FACP

Alexander Spira, MD, PhD, discusses how he chooses treatment for patients with lung cancer.

Alexander Spira, MD, PhD, a medical oncologist and director of the Virginia Cancer Specialists Research Institute and the Phase 1 Trial Program, discusses how he chooses treatment for patients with lung cancer.

Spira says the treatment decisions for patients with lung cancer have become more complicated for the non-biomarker-driven patient population, or patients without an actionable mutation. More Here From Targeted Oncology